Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-030744
Filing Date
2010-05-27
Accepted
2010-05-27 14:07:45
Documents
1
Period of Report
2010-05-25

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c01820_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c01820_4x0.xml 4 14388
  Complete submission text file 0001209191-10-030744.txt   16975
Mailing Address 51 MADISON AVE 31ST FLOOR NEW YORK NY 10010
Business Address 51 MADISON AVE 31ST FLOOR NEW YORK NY 10010 646-282-3131
ACCRETIVE INVESTORS SBIC LP (Reporting) CIK: 0001262312 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34746 | Film No.: 10861942

Mailing Address 401 NORTH MICHIGAN AVENUE SUITE 2700 CHICAGO IL 60611
Business Address 401 NORTH MICHIGAN AVENUE SUITE 2700 CHICAGO IL 60611 312-324-7820
Accretive Health, Inc. (Issuer) CIK: 0001472595 (see all company filings)

EIN.: 020698101 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8741 Services-Management Services

Mailing Address 51 MADISON AVE 31ST FLOOR NEW YORK NY 10010
Business Address 51 MADISON AVE 31ST FLOOR NEW YORK NY 10010 646-282-3131
Accretive Associates SBIC, LLC (Reporting) CIK: 0001492319 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34746 | Film No.: 10861941